Silence Therapeutics plc Contract Liability (Deferred Revenue)
Silence Therapeutics plc (SLN) had Contract Liability (Deferred Revenue) of $0 as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-10
- 2026-06-30: Contract with Customer, Liability, Current $0.00.
- 2026-03-31: Contract with Customer, Liability, Current $0.00.
- 2025-12-31: Contract with Customer, Liability, Current $168.00K.
- 2025-09-30: Contract with Customer, Liability, Current $301.00K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-10 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 |
| 2025-12-31 | $168.00K 10-Q · filed 2026-08-10 |
| 2025-09-30 | $301.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $457.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $392.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $306.00K 10-K · filed 2026-03-05 |
| 2023-12-31 | $6.57M 10-K · filed 2025-02-27 |